Stanford University researchers unveiled their novel 18F-DASA-23 radiopharmaceutical during the Society of Nuclear Medicine and Molecular Imaging’s virtual meeting.
The nation's largest commercial health insurer is pausing implementation until "at least the end of the national public health emergency period," the organization said recently.
SNMMI President Alan Packard, PhD, told Health Imaging he was "extremely surprised" PET imaging wasn't listed as a requirement for Biogen's aducanumab.
The Medical Imaging Drugs Advisory Committee reviews data on radiopharmaceuticals and contrast media, recommending best practices to the agency's commissioner.
Although the combination of specific brain MRI results and SARS-CoV-2 in the spinal fluid are rare, the findings can help as society moves into the post-pandemic era.